Skip to main content


      Our research finds that Life Sciences CEOs are confident in industry growth fueled by innovation, technological advancement, and operational efficiency. There is a strong appetite for mergers and acquisitions, substantial investments in AI and digitalization, and a critical need to empower the workforce to navigate rapid change. While sustainability and ESG remain high on the agenda for Life Sciences organizations globally, there are shifting priorities across regions.


      Ai woman with glasses and data behind her

      KPMG 2025 Global Life Sciences CEO Outlook

      KPMG 2025 Global Life Sciences CEO Outlook

      Key findings

      86% have a moderate-to-high appetite for M&A over the next three years.

      25% integrate the costs and ROI of sustainability initiatives into every major capital investment.

      73% expect most corporate staff to be working in hybrid models within three years.

      Why download the report?

      By downloading the 2025 Life Sciences CEO Outlook, you’ll unlock unique perspectives on:

      • Industry growth prospects and drivers, M&A appetite, and operational challenges
      • AI and other capabilities investment
      • Workforce challenges and transformation
      • Evolution of ESG strategies

      Enhance your strategic planning with expert analysis and actionable insights.

      Empower your business strategy with data-driven perspectives from global CEOs. Gain clarity on emerging trends and the strategic moves shaping the future of technology and telecommunications.

      Featured

      The sector contributes to our most important possession: our health.